Introduction
Halosin is a general anesthetic. It is used in major surgical procedures. It allows the procedures to be carried out without pain and distress. This medicine is used in a hospital setting only.
Halosin is used in general anesthesia. It causes loss of consciousness which is reversible. It is administered under the supervision of a healthcare professional.
The most common side effects include shivering, nausea, vomiting, high grade fever, decreased blood pressure, and irregular heartbeat. Inform your doctor if you are pregnant or breastfeeding.
Also, inform your doctor if you are on any medications or have any known allergy to this medicine before the start of the procedure. Driving should not be done as this medicine may cause sleepiness and may impair your ability to think or react. It is also advised not to operate machinery because of these effects.
Side effects of Halosin
Common
- Shivering
- Vomiting
- Nausea
- High grade fever
- Decreased blood pressure
How to use Halosin
Use it as advised by your doctor or check the label for directions before use.
How Halosin works
Halosin is a general anaesthetic. It works by causing reversible loss of consciousness. This allows surgical procedures to be carried out without pain and distress.
Indication
Induction and maintenance of general anaesthesia
Adult Dose
Inhalation
Induction and maintenance of general anaesthesia
Adult: Induction: 0.5% v/v of halothane in oxygen or mixture of nitrous oxide and oxygen, increase gradually according to response to a concentration of 2-4% v/v. Maintenance: 0.5-2% v/v depending on the flow rate used.
Child Dose
Inhalation
Induction and maintenance of general anaesthesia
Child: Induction: 1.5-2% v/v. Maintenance: 0.5-1.5% v/v.
Contraindication
Known or suspected susceptibility to malignant hyperthermia, raised CSF pressure, history of unexplained jaundice or acute hepatic damage from previous exposure to halothane. Childn <18 yr undergoing outpatient dental surgery.
Mode of Action
Halothane is a potent non-flammable inhalational anaesth which depresses both cerebral function and sympathetic activity. It suppresses salivary, bronchial and gastric secretions and dilates the bronchioles.
Precaution
Patient w/ phaeochromocytoma, myasthenia gravis, renal failure, pre-existing hepatic disease. Childn. Pregnancy and lactation. Patient Counselling May impair ability to drive or operate machinery. Monitoring Parameters Monitor pulse and BP.
Side Effect
Post-op nausea, vomiting, and shivering; resp depression, hypotension, skeletal muscle relaxation, bradycardia.
Potentially Fatal: Hepatotoxicity, malignant hyperthermia, cardiac arrhythmias.
Interaction
Increased risk of ventricular dysrhythmias w/ epinephrine. Increased risk of malignant hyperthermia w/ suxamethonium. Prolonged recovery from anaesth w/ concurrent use of ketamine for induction. May potentiate response to non-depolarising muscle relaxants, hypotensive agents (e.g. hexamethonium bromide, trimetaphan camsilate).